Loading organizations...

Comet Biorefining is a technology company.
Comet Biorefining has raised $22.0M across 1 funding round.
Comet Biorefining has raised $22.0M in total across 1 funding round.
COMET has perfected nature's best dietary fiber, arabinoxylan, in our proprietary line of Arrabina® prebiotic fibers. Developed with sustainability at its core, Arrabina is at the forefront of the new wave of prebiotic dietary fibers.
Comet Biorefining is a food technology company that develops and produces Arrabina, a proprietary line of prebiotic dietary fibers derived from arabinoxylan extracted via patented upcycling technology from crop leftovers.[1][2][5] It serves food and beverage manufacturers seeking natural, functional ingredients to address dietary fiber shortages, solving problems like low fiber intake (90% of Americans fall short), poor gut health, unstable blood glucose, and weak immunity by offering fibers that support bifidobacteria growth, maintain healthy glucose levels, and integrate seamlessly without impacting taste or performance.[1][5] The company, headquartered in London, Ontario, Canada, and Schaumburg, Illinois, USA, has shown strong growth momentum, including a $25 million Series C funding round for innovation and commercialization, a partnership to expand production to over 4 million kg annually in Denmark, and awards like "Start-Up of the Year" in 2020.[1][2]
Founded in 2009 by Andrew Richard, Comet Biorefining emerged from the need to unlock arabinoxylan—a potent soluble dietary fiber dormant in agricultural byproducts—from the modern food system's waste stream.[1][4][5] The idea stemmed from recognizing a massive U.S. fiber gap (2 million tons annually) and developing patented upcycling tech to extract and purify it into versatile Arrabina fibers.[5] Early traction included positive clinical trial results validating health benefits, opening a U.S. headquarters in Chicagoland, equity financings like a $22M round, and partnerships with investors such as Sofinnova Partners, BDC Capital, Louis Dreyfus Company Ventures, Open Prairie, and PM Equity Partner.[2][3]
Comet rides the sustainable food tech and prebiotic boom, capitalizing on rising demand for functional fibers amid chronic underconsumption and trends in gut health, immunity, and clean-label ingredients.[1][5] Timing aligns with regulatory pushes for sustainability (e.g., upcycling certs) and post-pandemic focus on metabolic health, fueled by market forces like fiber-fortified products in a $50B+ functional food sector.[2] By upcycling ag waste, it reduces environmental impact in industrial biotech, influences ecosystems via partnerships (e.g., RE Energy, Givaudan), and enables manufacturers to meet consumer demands for natural prebiotics over synthetic alternatives.[1][2][5]
Comet is poised for explosive scaling with its new Denmark facility and funding fueling Arrabina commercialization, potentially capturing share in the growing prebiotic market amid fiber fortification mandates and sustainability regs.[1][2] Trends like personalized nutrition, AI-driven formulation, and global ag waste valorization will propel it, evolving its role from innovator to key supplier influencing food system sustainability. This positions Comet to close the fiber gap profitably, transforming waste into health via biorefining prowess.[5]
Comet Biorefining has raised $22.0M in total across 1 funding round.
Comet Biorefining's investors include Open Prairie, Soffinova Partners, BDC Capital, Louis Dreyfus Company.
Comet Biorefining has raised $22.0M across 1 funding round. Most recently, it raised $22.0M Series C in July 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2021 | $22.0M Series C | Open Prairie | Soffinova Partners, BDC Capital, Louis Dreyfus Company |